Cargando…

The Role of Inflammation in the Treatment of Schizophrenia

Background: Inflammation plays a major role in the onset and maintenance of schizophrenia. The objective of the present work was to synthetize in a narrative review the recent findings in the field of inflammation in schizophrenia and their application in daily practice. Method: This review was base...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fond, Guillaume, Lançon, Christophe, Korchia, Theo, Auquier, Pascal, Boyer, Laurent
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Psychiatry
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7093323/ https://www.ncbi.nlm.nih.gov/pubmed/32256401 http://dx.doi.org/10.3389/fpsyt.2020.00160

Ejemplares similares

C-Reactive Protein as a Peripheral Biomarker in Schizophrenia. An Updated Systematic Review
por: Fond, Guillaume, et al.
Publicado: (2018)

Microbiota-Orientated Treatments for Major Depression and Schizophrenia
por: Fond, Guillaume B., et al.
Publicado: (2020)

Brain SPECT perfusion and PET metabolism as discordant biomarkers in major depressive disorder
por: Tastevin, Maud, et al.
Publicado: (2020)

Mortalité dans la schizophrénie : vers un nouveau scandale sanitaire ? COVID-19 et schizophrénie
por: Fond, Guillaume, et al.
Publicado: (2021)

Disparities in Intensive Care Unit Admission and Mortality Among Patients With Schizophrenia and COVID-19: A National Cohort Study
por: Fond, Guillaume, et al.
Publicado: (2020)

The Validity of the SQoL-18 in Patients with Bipolar and Depressive Disorders: A Psychometric Study from the PREMIUM Project
por: Boyer, Laurent, et al.
Publicado: (2022)

Pregnancy, delivery and neonatal complications in women with schizophrenia: a national population-based cohort study
por: FABRE, Cyprien, et al.
Publicado: (2021)

Disparities in suicide mortality trends between United States of America and 25 European countries: retrospective analysis of WHO mortality database
por: Fond, Guillaume, et al.
Publicado: (2016)

Differentiating people with schizophrenia from healthy controls in a developing Country: An evaluation of portable functional near infrared spectroscopy (fNIRS) as an adjunct diagnostic tool
por: Tran, Bach Xuan, et al.
Publicado: (2023)

Editorial: The Role of Inflammation in the Etiology and Treatment of Schizophrenia
por: Köhler-Forsberg, Ole, et al.
Publicado: (2020)

You get psychotropic drugs, so you don’t need vaccination against Covid 19?
por: Fond, G., et al.
Publicado: (2021)

Toward Meeting the Needs of Homeless People with Schizophrenia: The Validity of Quality of Life Measurement
por: Auquier, Pascal, et al.
Publicado: (2013)

Quality of life among caregivers of patients with schizophrenia: a cross-cultural comparison of Chilean and French families
por: Boyer, Laurent, et al.
Publicado: (2012)

Psychometric properties of the Ruminative Response Scale-short form in a clinical sample of patients with major depressive disorder
por: Parola, Nathalie, et al.
Publicado: (2017)

Psychometric properties of the abbreviated version of the Scale to Assess Unawareness in Mental Disorder in schizophrenia
por: Michel, Pierre, et al.
Publicado: (2013)

Reducing Health Inequalities in Individuals with Severe Mental Disorders: Harnessing Real-World Data and Patient-Reported Measures
por: Boyer, Laurent, et al.
Publicado: (2023)

Virtual reality cue exposure therapy for tobacco relapse prevention: a comparative study with standard intervention
por: Malbos, Eric, et al.
Publicado: (2023)

The Prevalence of Mental Disorders Among Children and Adolescents in the Child Welfare System: A Systematic Review and Meta-Analysis
por: Bronsard, Guillaume, et al.
Publicado: (2016)

A Bayesian framework systematic review and meta-analysis of anesthetic agents effectiveness/tolerability profile in electroconvulsive therapy for major depression
por: Fond, Guillaume, et al.
Publicado: (2016)

Development and Calibration of the PREMIUM Item Bank for Measuring Respect and Dignity for Patients with Severe Mental Illness
por: Fernandes, Sara, et al.
Publicado: (2022)

End of life breast cancer care in women with severe mental illnesses
por: Fond, Guillaume, et al.
Publicado: (2021)

Machine-learning prediction for hospital length of stay using a French medico-administrative database
por: Jaotombo, Franck, et al.
Publicado: (2022)

Neurocognition, Insight and Medication Nonadherence in Schizophrenia: A Structural Equation Modeling Approach
por: Boyer, Laurent, et al.
Publicado: (2012)

Medication nonadherence among South American patients with schizophrenia
por: Caqueo-Urízar, Alejandra, et al.
Publicado: (2017)

Confirmation of a Two-Factor Solution to the Questionnaire of Cognitive and Affective Empathy in a French Population of Patients With Schizophrenia Spectrum Disorders
por: Brunet-Gouet, Eric, et al.
Publicado: (2019)

Uric Acid Potential Role in Systemic Inflammation and Negative Symptoms After Acute Antipsychotic Treatment in Schizophrenia
por: Borovcanin, Milica M., et al.
Publicado: (2022)

Increased in-hospital mortality from COVID-19 in patients with schizophrenia
por: Fond, G., et al.
Publicado: (2021)

Machine-learning prediction of unplanned 30-day rehospitalization using the French hospital medico-administrative database
por: Jaotombo, Franck, et al.
Publicado: (2020)

Victimization and posttraumatic stress disorder in homeless women with mental illness are associated with depression, suicide, and quality of life
por: Tinland, Aurelie, et al.
Publicado: (2018)

Impact of the COVID-19 pandemic on non-COVID-19 hospital mortality in patients with schizophrenia: a nationwide population-based cohort study
por: Boyer, Laurent, et al.
Publicado: (2022)

Schizophrenia pregnancies should be given greater health priority in the global health agenda: results from a large-scale meta-analysis of 43,611 deliveries of women with schizophrenia and 40,948,272 controls
por: Etchecopar-Etchart, Damien, et al.
Publicado: (2022)

Quality of life is predictive of relapse in schizophrenia
por: Boyer, Laurent, et al.
Publicado: (2013)

Neural substrate of quality of life in patients with schizophrenia: a magnetisation transfer imaging study
por: Catherine, Faget-Agius, et al.
Publicado: (2015)

Quality of life is associated with chronic inflammation in schizophrenia: a cross-sectional study
por: M., Faugere, et al.
Publicado: (2015)

Calibration and Validation of a PREMIUM-DT Item Bank to Measure the Experience of Drug Therapy for Patients with Severe Mental Illness
por: Fernandes, Sara, et al.
Publicado: (2022)

Corrigendum: Neural substrate of quality of life in patients with schizophrenia: a magnetisation transfer imaging study
por: Faget-Agius, Catherine, et al.
Publicado: (2016)

Complex Gastrointestinal and Endocrine Sources of Inflammation in Schizophrenia
por: Severance, Emily G., et al.
Publicado: (2020)

Inflammation and viral infection as disease modifiers in schizophrenia
por: Klein, Hans C., et al.
Publicado: (2023)

The Covid-19 infection: An opportunity to develop systematic vitamin D supplementation in psychiatry
por: Fond, G., et al.
Publicado: (2022)

Improvement of health-related quality of life in depression after transcranial magnetic stimulation in a naturalistic trial is associated with decreased perfusion in precuneus
por: Dumas, Rémy, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_hr872ojlbh49rkq83cnj0nanbh